Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18053
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSood, Siddharth-
dc.contributor.authorHaifer, C-
dc.contributor.authorYu, L-
dc.contributor.authorPavlovic, J-
dc.contributor.authorGow, Paul J-
dc.contributor.authorJones, Robert M-
dc.contributor.authorVisvanathan, Kumar-
dc.contributor.authorAngus, Peter W-
dc.contributor.authorTestro, Adam G-
dc.date2018-05-29-
dc.date.accessioned2018-07-10T06:34:24Z-
dc.date.available2018-07-10T06:34:24Z-
dc.date.issued2018-05-29-
dc.identifier.citationTransplant Infectious Disease : an Official Journal of the Transplantation Society 2018; 20(5): e12934en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18053-
dc.description.abstractAlthough antiviral prophylaxis is effective in preventing early cytomegalovirus (CMV) reactivation following liver transplantation (OLT), it predisposes patients to late CMV after prophylaxis has ceased. QuantiFERON-CMV (QFN-CMV, Qiagen, The Netherlands) measures an individual's viral-specific immune response. Fifty-nine OLT recipients were prospectively monitored post-OLT in an observational cohort study. QFN-CMV was performed at regular time-points. An absolute QFN-CMV <0.1 IU/mL was considered non-reactive. 50/59 (84.7%) had a reactive QFN-CMV by M6. 38/59 (64.4%) had antiviral prophylaxis or treatment before M6, with 31/38 (81.6%) developing a reactive QFN-CMV by 6 months. Over 90% already had a reactive result as early as 3 months post transplant, 3 patients (5.08%) developed late CMV between 6-12 months (median 251 days)-all had a non-reactive M6 QFN-CMV. And 2/3 experienced CMV disease. Non-reactive M6 QFN-CMV was significantly associated with late CMV (OR = 54.4, PPV = 0.33, NPV = 1.00, P = .003). Although only 5% of recipients developed late CMV, 2/3 suffered CMV disease. M6 QFN-CMV has an excellent NPV for late CMV, suggesting patients who exhibit a robust ex vivo immune response at M6 can safely cease CMV monitoring. Furthermore, >90% already express viral-specific immunity as early as 3 months. Conceivably, antiviral prophylaxis could be discontinued early in these patients.en_US
dc.language.isoeng-
dc.subjectCMV diseaseen_US
dc.subjectQFNCMVen_US
dc.subjectcytomegalovirusen_US
dc.subjectlate CMVen_US
dc.subjectliver transplantationen_US
dc.subjectquantiferon-CMVen_US
dc.titleEarly viral-specific T-cell testing predicts late cytomegalovirus reactivation following liver transplantation.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleTransplant Infectious Disease : an Official Journal of the Transplantation Societyen_US
dc.identifier.affiliationVictorian Liver Transplant Uniten_US
dc.identifier.affiliationDepartment of Gastroenterology & Hepatology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationInnate Immune Laboratory, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australiaen_US
dc.identifier.doi10.1111/tid.12934en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-9341-4792en_US
dc.identifier.pubmedid29809312-
dc.type.austinJournal Article-
local.name.researcherAngus, Peter W
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptSurgery (University of Melbourne)-
crisitem.author.deptHepatopancreatobiliary Surgery-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Apr 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.